DIPG/DIPT Discussion

brought to you by

Just One More Day for Love, Hope & a Cure

A searchable blog on DIPG research, DIPG news, recent publications, DIPG Foundations, DIPG researchers, clinical trials as well as other issues relating to Diffuse Intrinsic Pontine Tumors- both Diffuse Intrinsic Pontine Gliomas (DIPGs) and Atypical Pontine Lesions (APLs).

For parents, family and friends of children with DIPG looking for information and connection to others dealing with DIPG please check the buttons on the right hand side for resources.

Monday, March 18, 2013

New Trial- MGMT Cancer Gene Therapy Trial

One of the huge problems with chemotherapy is that it beats up normal cells- especially bone marrow.   The toxicity limits how far the doctors can increase dosages before it is just too much for the body.  One novel idea is to try to make the normal bone marrow cells more resistant to chemotherapy.  This is exactly what researchers are trying to do with a gene therapy which effects MGMT.  This will allow for increasing doses of temozolomide.

Dr Geoffrey McCowage at The Children's Hospital of Westmead in Sydney Australia has spent the last 15 years developing a trial which removes bone marrow stem cells, genetically modifies the NA repair protein and then reinserts them into the patient.   The hope is that this modification will allow a patient to withstand escalating chemotherapy while better targeting the tumor.   In fact, this is more than theory.    This first of kind therapy for brain tumor kids is open in trial.

This Phase 1 intervention is open to several different types of brain tumors including brainstem glioma of diffuse pontine type  and all the following recurrent tumors- medulloblastoma, ependymoma, atypical teratoid rhaboid, high and low grade glioma.

Erin is the first child enrolled.   You can read at-
Last month she had reached a year from diagnosis- and in the picture she looks great.

The trial is being funded by the Kid's Cancer Project (formerly Oncology Children's Foundation),  Sporting Chance Cancer Foundation and the Australian governmental funding agency, The Department of Innovation, Industry Science and Research.

Erin is hoping to raise $50,000 for The Cure Starts Now for DIPG research.

Note- A similar trial seems to be open in the US at the NIH for adult glioblastoma patients.


Cancer Gene Therapy Project (Westmead Research site)- 

Australian New Zealand Clinical Trial Registry (ANZCTR)-

NIH Adult Trial with Newly Diagnosed GBM- http://www.clinicaltrials.gov/ct2/show/NCT01269424